DSM Biomedical, a company focused on biomedical materials science, has entered into a license and supply agreement with orthopedic device maker Interventional Spine, according to a company news release.
The agreement allows Interventional Spine to use Bionate PCU, a proprietary DSM polymer, in its Percutaneous Dynamic Stabilization system, a percutaneous bilateral facet-augmentation system for treating degenerative disc disease and lumbar spinal stenosis. The PDS System implant is delivered percutaneously. Bionate PCU helps secure the implant in place as it flexes with the natural movement of the spine. Terms of the license and supply agreement were not disclosed but contain a mix of royalties on devices sold and annual fees.
Interventional Spine's PDS System received the CE Mark approval and is commercially available only outside the U.S.
Read the company news release about DSM Biomedical and Interventional Spine.
Read other coverage about device news:
- FDA Warning Letter to Anulex Leads to Layoffs
- Centinel Spine Reports 47% Increase in Q1 Sales
- Medical Device Industry Hopes Intense Lobbying Will Overturn Excise Tax
The agreement allows Interventional Spine to use Bionate PCU, a proprietary DSM polymer, in its Percutaneous Dynamic Stabilization system, a percutaneous bilateral facet-augmentation system for treating degenerative disc disease and lumbar spinal stenosis. The PDS System implant is delivered percutaneously. Bionate PCU helps secure the implant in place as it flexes with the natural movement of the spine. Terms of the license and supply agreement were not disclosed but contain a mix of royalties on devices sold and annual fees.
Interventional Spine's PDS System received the CE Mark approval and is commercially available only outside the U.S.
Read the company news release about DSM Biomedical and Interventional Spine.
Read other coverage about device news:
- FDA Warning Letter to Anulex Leads to Layoffs
- Centinel Spine Reports 47% Increase in Q1 Sales
- Medical Device Industry Hopes Intense Lobbying Will Overturn Excise Tax